Bioton S.A. Logo

Bioton S.A.

A global manufacturer of recombinant human insulin and diabetes care solutions.

BIO | WAR

Overview

Corporate Details

ISIN(s):
PLBIOTN00029
LEI:
259400I5R1L3OPCGII81
Country:
Poland
Address:
Warszawa Starościńska 5, 02-516 Warszawa

Description

Bioton S.A. is a biotechnology company focused on providing comprehensive solutions for diabetes care. The company's core activity is the development and production of recombinant human insulin, positioning it as a significant commercial manufacturer globally. Its operations cover the full biotechnological process, from DNA research and development to the manufacturing and marketing of finished medicinal products. The product portfolio is centered on various forms of insulin and is complemented by modern automatic injection systems designed to facilitate effective diabetes treatment for patients.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2021-08-31 17:10
Raport biegłego rewidenta 1H 2021 skonsolidowane
Polish 531.7 KB
2021-08-31 17:10
Sprawozdanie Zarządu 1H 2021
Polish 517.0 KB
2021-08-31 17:10
Sprawozdanie finansowe 1H 2021 jednostkowe
Polish 584.5 KB
2021-08-31 17:10
Sprawozdanie finansowe 1H 2021 skonsolidowane
Polish 615.2 KB
2021-06-29 22:10
Powołanie osób nadzorujących BIOTON S.A. - korekta - Content (PL)
Polish 839 bytes
2021-06-28 15:41
Tomasz Siembida CV
Polish 123.5 KB
2021-06-28 15:41
Yuhong Geng CV
Polish 199.1 KB
2021-06-28 15:41
Hau Khee Wee CV
Polish 132.3 KB
2021-06-28 15:41
Powołanie osób nadzorujących BIOTON S.A. - Content (PL)
Polish 503 bytes
2021-06-28 15:24
Uchwały ZWZ Bioton S.A.
Polish 242.2 KB
2021-06-28 15:24
Uchwały podjęte przez Zwyczajne Walne Zgromadzenie BIOTON S.A. w dniu 28 czerwc…
Polish 241 bytes
2021-06-28 15:11
Lista Akcjonariuszy_5%_ZWZ_28 czerwca 2021
Spanish 159.1 KB
2021-06-28 15:11
Lista akcjonariuszy posiadających co najmniej 5% liczby głosów na ZWZ BIOTON S.…
Polish 328 bytes
2021-06-16 16:19
CV_Khee Wee Hau
Polish 132.3 KB
2021-06-16 16:19
CV_Yuhong Geng
Polish 199.1 KB

Automate Your Workflow. Get a real-time feed of all Bioton S.A. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Bioton S.A.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Bioton S.A. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.